AMANDA LEWIS: Open Payments
NPI 1679061691 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,728 in 146 payments from 20 companies in 2025. Trend: 2023 $3,564 · 2024 $3,508 · 2025 $2,728
Food & beverage: $2,728
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $511 |
| ABBVIE INC. | 20 | $404 |
| Novo Nordisk Inc | 17 | $277 |
| PFIZER INC. | 15 | $266 |
| Lilly USA, LLC | 8 | $168 |
| GlaxoSmithKline, LLC. | 16 | $165 |
| Dexcom, Inc. | 7 | $163 |
| Amgen Inc. | 12 | $156 |
| Phathom Pharmaceuticals, Inc. | 7 | $133 |
| Axsome Therapeutics, Inc. | 4 | $109 |
Products named: FARXIGA, NURTEC ODT, VRAYLAR, Wegovy, QULIPTA, AIRSUPRA, Dexcom G6 Transmitter, MOUNJARO.
Industry payments across FL — which companies pay providers there.
